Different refractive errors in triplets with retinopathy of prematurity treated with bevacizumab. [electronic resource]
Producer: 20130912Description: e41-3 p. digitalISSN:- 1938-2405
- Angiogenesis Inhibitors -- adverse effects
- Antibodies, Monoclonal, Humanized -- adverse effects
- Bevacizumab
- Female
- Gestational Age
- Humans
- Hyperopia -- chemically induced
- Infant, Newborn
- Infant, Premature
- Infant, Very Low Birth Weight
- Intravitreal Injections
- Male
- Myopia -- chemically induced
- Retinopathy of Prematurity -- classification
- Triplets
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.